Skip to content

Clinical trials

Recruiting Breast Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Status: Recruiting Country / region: South Korea Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20202
20214
202211
202317
202415
202530
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting89

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Samsung Medical Center7
Hoffmann-La Roche6
Merck Sharp & Dohme LLC5
Gangnam Severance Hospital4
Seoul National University Hospital4
Novartis Pharmaceuticals3
Yonsei University3
Asan Medical Center2
Daiichi Sankyo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms89
Colorectal Neoplasms9
Neoplasm Metastasis9
Carcinoma, Non-Small-Cell Lung8
Ovarian Neoplasms8
Endometrial Neoplasms7
Stomach Neoplasms7
Neoplasms6
Lung Neoplasms5
Pancreatic Neoplasms5

Trials

Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.